Chloroquine and hydroxychloroquine for COVID-19: implications for cardiac safety
- PMID: 32347923
- PMCID: PMC7197554
- DOI: 10.1093/ehjcvp/pvaa041
Chloroquine and hydroxychloroquine for COVID-19: implications for cardiac safety
Comment on
-
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro.Cell Res. 2020 Mar;30(3):269-271. doi: 10.1038/s41422-020-0282-0. Epub 2020 Feb 4. Cell Res. 2020. PMID: 32020029 Free PMC article. No abstract available.
-
Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro.Cell Discov. 2020 Mar 18;6:16. doi: 10.1038/s41421-020-0156-0. eCollection 2020. Cell Discov. 2020. PMID: 32194981 Free PMC article. No abstract available.
References
-
- Jeevaratnam K, Guzadhur L, Goh YM, Grace AA, Huang CL.. Sodium channel haploinsufficiency and structural change in ventricular arrhythmogenesis. Acta Physiol (Oxf) 2016;216:186–202. - PubMed